Two trials of Merck's investigational monthly HIV-prevention pill have finished adult enrollment.
Two trials of Merck's investigational monthly HIV-prevention pill have finished adult enrollment. Stock Titan
Read the full story on Stock Titan → Opens the original article on news.google.comSummary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.